跳至主要内容
临床试验/JPRN-UMIN000015519
JPRN-UMIN000015519已完成未知

A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer - A comparative study on the efficacies of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist in neoadjuvant androgen deprivation therapy combined with transperineal prostate brachytherapy for localized prostate cancer

Jikei University School of Medicine0 个研究点目标入组 56 人开始时间: 2014年11月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Have previously received hormonal therapies including GnRH agonists, GnRH antagonists, and antiandrogen agents, estorogen agents or orchiectomy for PCa 2) Be using 5alpha reductase inhibitor 3) Have severe asthma (e.g. use inhaled corticosteroid that is necessary for daily life), anaphylactic reaction, severe urticaria and complication or medical history of angioedema 4) Be sensitive to mannitol 5) Have multiple malignancies 6) Have ALT>= 100 IU/L or total bilirubin >= 1.3 mg/dL 7) Be considered as inappropriate by the investigator

研究者

相似试验